Literature DB >> 21447895

Peri-ictal and ictal cognitive dysfunction in epilepsy.

Lavanya Vijayaraghavan1, Subbulakshmy Natarajan, Ennapadam Srinivas Krishnamoorthy.   

Abstract

Disturbances in cognitive function, particularly memory, are a common complaint of patients with epilepsy. Factors contributing to cognitive dysfunction are the type of epilepsy, type and frequency of seizures, anti-epileptic drugs and the location of underlying brain lesions. Whilst a great deal of attention has been paid to permanent cognitive impairment, the nature and underlying mechanisms of ictal and peri-ictal cognitive changes are poorly understood. In-depth investigation of seizure related cognitive dysfunction is of great clinical relevance, as these changes are potentially reversible and treatable, thus reducing the cumulative effect of frequent seizures. Greater knowledge of peri-ictal and ictal cognitive dysfunction would improve seizure prediction, localization of seizure focus and assessment of treatment effectiveness, greatly reducing distress and disability. This paper will review current understanding of peri-ictal and ictal cognitive dysfunction and discuss future directions for research.

Entities:  

Mesh:

Year:  2011        PMID: 21447895      PMCID: PMC5377961          DOI: 10.3233/BEN-2011-0320

Source DB:  PubMed          Journal:  Behav Neurol        ISSN: 0953-4180            Impact factor:   3.342


  2 in total

1.  The PPARγ agonist rosiglitazone prevents cognitive impairment by inhibiting astrocyte activation and oxidative stress following pilocarpine-induced status epilepticus.

Authors:  Sun Hong; Yu Xin; Wu HaiQin; Zhang GuiLian; Zhang Ru; Zhan ShuQin; Wang HuQing; Yao Li; Du Yun
Journal:  Neurol Sci       Date:  2011-09-14       Impact factor: 3.307

2.  Case Report: Not All Neurological Symptoms Respond Well to Penicillin in Patients With Neurosyphilis.

Authors:  Xiaoli Wang; Pengying Mu; Wenjuan Zhang; Yonghong Liu
Journal:  Front Neurol       Date:  2022-01-24       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.